finanzen.net
Jetzt neu: Eine Übersicht über von Corona besonders betroffene Aktien (positiv wie negativ)-w-

Sanofi Aktie WKN: 920657 / ISIN: FR0000120578

77,45EUR
-2,46EUR
-3,08%
14:00:18
77,16EUR
-3,12EUR
-3,89%
14:04:29
KAUFEN
VERKAUFEN
mehr Daten anzeigen
Werbung

Sanofi Aktien News

07:00 Uhr
Sanofi: Information on Sanofi’s Shareholder General Meeting of Tuesday, April 28, 2020 (GlobeNewswire)
30.03.20
Sanofi: First patient outside U.S. treated in global Kevzara® (sarilumab) clinical trial program for patients with severe COVID-19 (GlobeNewswire)
27.03.20
Sanofi and Translate Bio collaborate to develop novel mRNA vaccine candidate against COVID-19 (GlobeNewswire)
24.03.20
Sanofi successfully prices EUR 1.5 billion of bond issue (GlobeNewswire)
05.03.20
Sanofi : Filing of the 2019 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report (GlobeNewswire)
04.03.20
Sanofi's Board of Directors proposes the appointment of Rachel Duan and Lise Kingo as independent directors (GlobeNewswire)
02.03.20
Sanofi : FDA approves Sarclisa® (isatuximab-irfc) for patients with relapsed refractory multiple myeloma (GlobeNewswire)
24.02.20
Sanofi to create new industry leading European company to provide active pharmaceutical ingredients (API*) (GlobeNewswire)
18.02.20
Sanofi joins forces with U.S. Department of Health and Human Services to advance a novel coronavirus vaccine (GlobeNewswire)
06.02.20
Sanofi : Sanofi brain-penetrant BTK inhibitor meets primary endpoint of Phase 2 trial in relapsing multiple sclerosis (GlobeNewswire)
30.01.20
Sanofi : Positive topline results demonstrated by olipudase alfa, first and only investigational therapy in late-stage development for acid sphingomyelinase deficiency (GlobeNewswire)
28.01.20
Sanofi : FDA accepts for priority review Dupixent® (dupilumab) for children aged 6 to 11 years with moderate-to-severe atopic dermatitis (GlobeNewswire)
23.01.20
Sanofi : Sanofi Completes Acquisition of Synthorx, Inc. (GlobeNewswire)
20.01.20
Sanofi : Hart-Scott-Rodino waiting period expires for Sanofi’s acquisition of Synthorx (GlobeNewswire)
09.01.20
Sanofi : Availability of the Pre-quarterly Results Communication (GlobeNewswire)
23.12.19
Sanofi commences tender offer for acquisition of Synthorx, Inc. (GlobeNewswire)
10.12.19
Sanofi and Regeneron announce intent to restructure Antibody collaboration for Kevzara® (sarilumab) and Praluent® (alirocumab) (GlobeNewswire)
10.12.19
Sanofi : Positive results presented from pivotal Phase 3 trial of sutimlimab in people with cold agglutinin disease (GlobeNewswire)
09.12.19
Sanofi CEO unveils new strategy to drive innovation and growth (GlobeNewswire)
09.12.19
Sanofi : Sanofi to acquire Synthorx to bolster its immuno-oncology pipeline for $2.5 Billion (GlobeNewswire)
04.11.19
Sanofi : FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older (GlobeNewswire)
04.11.19
Sanofi : Positive results in Phase 3 trial for Toujeo® in children and adolescents with type 1 diabetes (GlobeNewswire)
29.10.19
Sanofi : Dupixent® (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis (GlobeNewswire)
15.10.19
Sanofi opens its first digitally-enabled, continuous manufacturing facility; ushers in next generation of biotech manufacturing (GlobeNewswire)
01.10.19
Sanofi : Availability of the Pre-quarterly Results Communication (GlobeNewswire)
30.09.19
Sanofi : New England Journal of Medicine publishes data showing improved survival with Jevtana® (cabazitaxel) over second androgen receptor-targeted agent in metastatic castration-resistant prostate c (GlobeNewswire)
20.09.19
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for severe chronic rhinosinusitis with nasal polyposis   (GlobeNewswire)
16.09.19
Sanofi and Abbott partner to integrate glucose sensing and insulin delivery technologies to help change the way diabetes is managed (GlobeNewswire)
28.08.19
Sanofi : U.S. District Court invalidates Amgen patent claims targeting PCSK9 (GlobeNewswire)
06.08.19
Sanofi : Dupixent® (dupilumab) showed positive topline results in Phase 3 trial of children aged 6 to 11 years with severe atopic dermatitis (GlobeNewswire)
06.08.19
Sanofi : Dupixent® (dupilumab) approved by European Commission for adolescents with moderate-to-severe atopic dermatitis (GlobeNewswire)
26.07.19
Sanofi :  Sanofi provides update on ZynquistaTM (sotagliflozin) type 2 diabetes Phase 3 program and collaboration with Lexicon (GlobeNewswire)
23.07.19
Sanofi signs strategic deal for exclusive US over-the-counter rights to Tamiflu® in Flu Care (GlobeNewswire)
10.07.19
Sanofi : FDA to review isatuximab as a potential treatment for relapsed/refractory multiple myeloma (GlobeNewswire)
02.07.19
Sanofi : Availability of the Pre-quarterly Results Communication (GlobeNewswire)
01.07.19
Sanofi : Libtayo® (cemiplimab) approved for advanced cutaneous squamous cell carcinoma in the European Union (GlobeNewswire)
28.06.19
Sanofi : CHMP recommends approval of Dupixent® (dupilumab) for moderate-to-severe atopic dermatitis in adolescents (GlobeNewswire)
27.06.19
Sanofi : FDA to review MenQuadfi, a meningococcal vaccine candidate (GlobeNewswire)
26.06.19
Sanofi : FDA approves Dupixent® (dupilumab) for chronic rhinosinusitis with nasal polyposis (GlobeNewswire)
21.06.19
Sanofi and Regeneron announce positive topline Phase 2 results for IL-33 antibody in asthma (GlobeNewswire)
Seite: 1234567

Sanofi News

Sanofi News: auf dieser Seite finden Sie alle Sanofi News und Nachrichten zur Sanofi Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sanofi News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sanofi News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Microsoft Corp.870747
Deutsche Bank AG514000
Wirecard AG747206
Lufthansa AG823212
Shell (Royal Dutch Shell) (A)A0D94M
Scout24 AGA12DM8
BioNTech SE (spons. ADRs)A2PSR2
Daimler AG710000
Amazon906866
Airbus SE (ex EADS)938914
Allianz840400
TeslaA1CX3T
Apple Inc.865985
NEL ASAA0B733
BayerBAY001